Financhill
Back

Tandem Diabetes Care Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
21

TNDM
Tandem Diabetes Care

Last Price:
34.19
Seasonality Move:
8.18%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Tandem Diabetes Care Price Quote

$34.19
+1.08 (+3.26%)
(Updated: November 6, 2024 at 5:55 PM ET)

Tandem Diabetes Care Key Stats

Sell
21
Tandem Diabetes Care (TNDM) is a Sell

Day range:
$32.66 - $33.88
52-week range:
$13.82 - $53.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.71
P/B ratio:
9.27%

Volume:
1M
Avg. volume:
1.3M
1-year change:
110.22%
Market cap:
$2.2B
Revenue:
$747.7M
EPS:
$-2.09

How Much Does Tandem Diabetes Care Make?

Is Tandem Diabetes Care Growing As A Company?

  • What Is Tandem Diabetes Care's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is Tandem Diabetes Care's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Tandem Diabetes Care Stock Price Performance

What Is Tandem Diabetes Care 52-Week High & Low?

Tandem Diabetes Care Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tandem Diabetes Care?

Is Tandem Diabetes Care Cash Flow Positive?

  • What Is TNDM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$20.4M
  • What Is Tandem Diabetes Care’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $11.3M
  • What Is Tandem Diabetes Care’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$73.7M

Tandem Diabetes Care Return On Invested Capital

  • Is Management Doing A Good Job?
    TNDM return on invested capital is -22.88%
  • What Is Tandem Diabetes Care Return On Assets?
    ROA measures how assets are converting to revenues and is -14.47%
  • What Is TNDM Return On Equity?
    ROE is a measure of profitability and is -47.6%

Tandem Diabetes Care Earnings Date & Stock Price

Tandem Diabetes Care Competitors

Tandem Diabetes Care Dividend Yield

Tandem Diabetes Care Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 10.05%
Revenue: 13.27% 7.79%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 52.16
Upside from Last Price: 57.53%

Major Shareholders

  • How many TNDM shares are owned by institutional investors?
    130.2M TNDM shares are owned by institutional investors
  • How many TNDM shares are owned by insiders?
    295.3K TNDM shares are owned by insiders